These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8458597)

  • 21. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
    Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of interaction between zolpidem and H2 antagonists, cimetidine and ranitidine.
    Hulhoven R; Desager JP; Harvengt C; Hermann P; Guillet P; Thiercelin JF
    Int J Clin Pharmacol Res; 1988; 8(6):471-6. PubMed ID: 3253224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.
    Cysneiros RM; Farkas D; Harmatz JS; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 2007 Jul; 82(1):54-62. PubMed ID: 17443132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers.
    Quera-Salva MA; McCann C; Boudet J; Frisk M; Borderies P; Meyer P
    Br J Clin Pharmacol; 1994 Jun; 37(6):539-43. PubMed ID: 7917771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic effects of simultaneous administration of single-dose gabapentin 500 mg and zolpidem tartrate 10 mg in healthy volunteers: a randomized, open-label, crossover trial.
    Galitz LA; Jayawardena S; Furey SA
    Drugs R D; 2015 Mar; 15(1):71-7. PubMed ID: 25567214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.
    Greenblatt DJ; Harmatz JS; Singh NN; Roth T; Harris SC; Kapil RP
    J Clin Pharmacol; 2013 Nov; 53(11):1194-8. PubMed ID: 23939537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure.
    Sanger DJ; Perrault G; Morel E; Joly D; Zivkovic B
    Physiol Behav; 1987; 41(3):235-40. PubMed ID: 3324120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone.
    Drover DR
    Clin Pharmacokinet; 2004; 43(4):227-38. PubMed ID: 15005637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential.
    Langtry HD; Benfield P
    Drugs; 1990 Aug; 40(2):291-313. PubMed ID: 2226217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between zolpidem concentrations and sleep parameters in pediatric burn patients.
    Stockmann C; Gottschlich MM; Healy D; Khoury JC; Mayes T; Sherwin CM; Spigarelli MG; Kagan RJ
    J Burn Care Res; 2015; 36(1):137-44. PubMed ID: 25185933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coadministration of short-term zolpidem with sertraline in healthy women.
    Allard S; Sainati SM; Roth-Schechter BF
    J Clin Pharmacol; 1999 Feb; 39(2):184-91. PubMed ID: 11563412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem.
    Luurila H; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Apr; 54(2):163-6. PubMed ID: 9626922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daytime sleep and performance following a zolpidem and melatonin cocktail.
    Wesensten NJ; Balkin TJ; Reichardt RM; Kautz MA; Saviolakis GA; Belenky G
    Sleep; 2005 Jan; 28(1):93-103. PubMed ID: 15700725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
    Roth T; Mayleben D; Corser BC; Singh NN
    Hum Psychopharmacol; 2008 Jan; 23(1):13-20. PubMed ID: 17907263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects.
    Dingemanse J; Bury M; Bock J; Joubert P
    Psychopharmacology (Berl); 1995 Nov; 122(2):169-74. PubMed ID: 8848532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men.
    Brunner DP; Dijk DJ; Münch M; Borbély AA
    Psychopharmacology (Berl); 1991; 104(1):1-5. PubMed ID: 1881993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD.
    Girault C; Muir JF; Mihaltan F; Borderies P; De La Giclais B; Verdure A; Samson-Dollfus D
    Chest; 1996 Nov; 110(5):1203-11. PubMed ID: 8915222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
    Bensimon G; Foret J; Warot D; Lacomblez L; Thiercelin JF; Simon P
    Br J Clin Pharmacol; 1990 Sep; 30(3):463-9. PubMed ID: 2223425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.